The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global stroke management market exhibited moderate growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 6% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
A stroke occurs when a blockage or bleeding in blood vessels prevents an adequate supply of oxygen and nutrients to the brain. Its effective management assists in reducing brain damage and other complications. Stroke management involves a complete initial evaluation and assessment of patients with acute stroke using an echocardiogram, carotid ultrasound, cerebral angiogram, blood tests, computerized tomography (CT) scan, and magnetic resonance imaging (MRI). As per the evaluation and assessment results and patient's condition, treatment options for stroke like intravenous (IV) medication, endovascular procedures, intubation, and surgeries are opted by physicians.
Chronic diseases, including hypertension, migraine, diabetes, dyslipidemia, obesity, cardiac diseases, atrial fibrillation, sickle cell, atrial fibrillation, carotid stenosis, and obstructive sleep apnea, are among the leading factors elevating the risk of stroke. This, in confluence with the increasing prevalence of these diseases among a significant part of the population, represents one of the primary factors escalating the need for stroke management across the globe. Additionally, physical inactivity, tobacco use, unhealthy diet and nutrition, and excessive drug and alcohol consumption are other factors influencing the market positively. Apart from this, due to the increasing geriatric population, which is more vulnerable to stroke, there is a rise in the demand for efficient stroke management. Furthermore, governing bodies of numerous countries are launching public health programs that encourage people to have periodic screening examinations for detecting chronic diseases. This, in confluence with the rising awareness among individuals about the advantages of early diagnosis and treatment, is leading to market growth. The approval of new and advanced devices and drugs is also creating a favorable outlook for the market.
IMARC Group provides an analysis of the key trends in each sub-segment of the global stroke management market report, along with forecasts for growth at the global, regional and country level from 2021-2026. Our report has categorized the market based on type, application and end user.
Breakup by Type:
Breakup by Application:
Breakup by End User:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, B. Braun Melsungen AG, Boston Scientific Corporation, Bristol-Myers Squibb Company, Cardinal Health, General Electric Company, GlaxoSmithKline plc, Medtronic plc, Merck & Co. Inc. and Siemens Healthineers AG (Siemens AG).
|Base Year of the Analysis||2020|
|Segment Coverage||Type, application, End User, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||Abbott Laboratories, B. Braun Melsungen AG, Boston Scientific Corporation, Bristol-Myers Squibb Company, Cardinal Health, General Electric Company, GlaxoSmithKline plc, Medtronic plc, Merck & Co. Inc. and Siemens Healthineers AG (Siemens AG).|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at